Recent Quarter Total Invested
$235,317
$37,681.00
Recent Quarter Institutional Ownership Percentage
3.8%
-$0.77
Total Invested of Last Quarter
$197,636
Ownership Percentage of Last Quarter
4.57%
Xenetic Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 99,507 | $40,000 | -30.61% | 0.66% |
| VANGUARD GROUP INC | 07/14/2023 | 96,982 | $39,375 | -38.86% | 0.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 91,545 | $37,716 | -0.86% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 77,819 | $32,061 | 210.78% | 0.51% |
| HRT FINANCIAL LP | 05/12/2023 | 37,473 | $15,000 | -33.64% | 0.25% |
| STATE STREET CORP | 05/15/2023 | 34,668 | $14,283 | 0.00% | 0.23% |
| JTC EMPLOYER SOLUTIONS TRUSTEE LTD | 04/26/2023 | 26,991 | $11,000 | 0.00% | 0.18% |
| TWO SIGMA SECURITIES, LLC | 05/15/2023 | 20,224 | $8,211 | 100.00% | 0.13% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/15/2023 | 19,000 | $7,714 | 0.00% | 0.13% |
| NORTHERN TRUST CORP | 05/15/2023 | 17,760 | $7,211 | 0.00% | 0.12% |
| CITADEL ADVISORS LLC | 05/15/2023 | 16,366 | $6,743 | -49.75% | 0.11% |
| ERGOTELES LLC | 05/10/2023 | 12,773 | $5,262 | -32.15% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 11,354 | $5,000 | 0.00% | 0.07% |
| GREAT VALLEY ADVISOR GROUP, INC. | 05/03/2023 | 10,600 | $4,304 | 0.00% | 0.07% |
| MORGAN STANLEY | 05/15/2023 | 2,952 | $1,199 | -50.54% | 0.02% |
| SIMPLEX TRADING, LLC | 04/27/2023 | 1,361 | $0 | 100.00% | 0.01% |
| NEWSQUARE CAPITAL LLC | 05/01/2023 | 260 | $106 | 0.00% | 0.00% |
| FMR LLC | 08/11/2023 | 217 | $89 | 1,105.56% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 105 | $43 | 1.94% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
Xenetic Biosciences, Inc.institutional Ownership - Frequently Asked Questions
-
What percentage of Xenetic Biosciences, Inc. stock is owned by institutional investors?
3.80% of Xenetic Biosciences, Inc. stock is owned by institutional investors.